No Cardioprotection Seen With Long-Term Metformin or Lifestyle Intervention Both approaches "highly effective" in T2D, but not for preventing CV disease, expert says May 24, 2022
SGLT2 Inhibitors a Better First Drug in Type 2 Diabetes Than Metformin? Observational study suggests some cardiovascular benefit May 23, 2022
Diabetic Pain Relief Lasts With High Frequency Spinal Cord Stimulation Trial followed patients with Senza System for 18 months May 16, 2022
Patients With Type 2 Diabetes and CKD Face Poor COVID Outcomes Severity of kidney disease ups risk of ICU time, in-hospital mortality, and more May 15, 2022
First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
GIP/GLP-1 Receptor Agonist Slashes Body Weight by More Than 20% "Impressive" topline results from trial in adults with overweight, obesity without diabetes May 02, 2022
More Evidence That Fenofibrate Slows Diabetic Eye Disease Significant decline in progression to vision-threatening status, proliferative retinopathy Apr 26, 2022
How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease? Study finds estimated annual progression rate to diabetes of 5.3% Apr 20, 2022
Who Is Really Driving Up Insulin Costs? More attention needs to focus on pharmaceutical middlemen Apr 18, 2022
In Type 2 Diabetes, Metabolic Control Could Add Years to Life Controlling four biomarkers could add as much as a decade to life expectancy Apr 18, 2022
The Winners and Losers of the Proposed Insulin Cost Cap While it benefits some, the $35 cap is only a stopgap measure Apr 08, 2022
Which Anticonvulsant Mood Stabilizer Upped Diabetes Risk? Observational study looked at 5-year risk differences between four agents Apr 06, 2022
Cannabis-Exposed Babies Face Poorer Metabolic Health By age 5, fat mass and glucose levels show the impact Mar 31, 2022
GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder? Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug Mar 28, 2022
Artificial Sweeteners Not So Sweet When It Comes to Cancer Risk Consumption of certain sugar alternatives linked to a 13% higher risk of developing cancer Mar 24, 2022
E-Cig Use Tied to Higher Odds of Prediabetes As in regular cigarettes, nicotine may play a role, researcher says Mar 03, 2022
Gestational Diabetes Risk Higher After Previous Miscarriage Risk increased with each prior spontaneous abortion Mar 03, 2022
Gastric Bypass Most Cost-Effective for Severe Obesity, T2D? Modeling study compares Roux-en-Y, conventional medical therapy, and sleeve gastrectomy Feb 14, 2022
FDA OKs 180-Day Implantable Continuous Glucose Monitor Senseonics' Eversense E3 System approved for adults with diabetes Feb 11, 2022
Novel Tirzepatide Wins as Insulin Glargine Add-On Another trial in the SURPASS clinical program met primary endpoint Feb 08, 2022
Gestational Diabetes Tied to Long-Term Cardiovascular Risks Chronic comorbidities partly explain risk, researcher says Feb 04, 2022
Warning Labels on Sugary Drinks: Do They Work? Randomized trial found picture warning labels turned parents off Feb 01, 2022
Obesity More Common in Type 1 Diabetes Than Expected And this is putting the population at a higher risk for chronic kidney disease, researchers say Jan 26, 2022
False Positive COVID Tests; Cannabis and Car Accidents Also in TTHealthWatch: diabetes risk among kids with COVID Jan 15, 2022 podcast
Semaglutide vs Liraglutide -- Which Induces More Weight Loss? The GLP-1 receptor agonists go head-to-head Jan 11, 2022
Weight-Loss Drug Wegovy Exceeded Expectations, and Supply Since its June approval, the injectable flew off shelves and into short supply Dec 29, 2021
Use of GLP-1 Receptor Agonists Scarce in Type 2 Diabetes Particularly so for racial/ethnic minority populations Dec 17, 2021
Wide Racial Gap for Diabetes Tech Use Among Medicare Patients Insulin pump and CGM use significantly lower among black patients Dec 15, 2021
Digital HTN, Diabetes Monitoring Program a Boon for Patients Program reports growth and better outcomes Dec 09, 2021
Type 1 vs Type 2 Youth-Onset Diabetes: Which Is Worse for the Eyes? One type had a higher risk for all diabetes-related ocular complications Dec 02, 2021
Another Study Confirms Gout Benefit With SGLT2 Inhibitors Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
Weight Loss Win for Weekly Injections of Novel Amylin Agent in Early Trial Cagrilintide at least on par with liraglutide after 26 weeks Nov 18, 2021
Blood-Based Biomarkers Prove Mettle in Liver Disease Diagnosis Data part of initiative to qualify biomarkers to help diagnose fibrosis or NASH Nov 15, 2021
More Good News for Empagliflozin in Patients With Heart Failure Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
Diuretic Bolstered Blood Pressure Control in Advanced CKD But some safety signals did arise in 12-week trial Nov 05, 2021
Liraglutide After Gastric Bypass Helped Stave Off Weight Regain The GLP-1 receptor agonist kept patients closer to nadir weight versus lifestyle management alone Nov 04, 2021
Childhood Obesity Is Soaring to New Levels Kids' weight has spiked during the pandemic, but it's part of a long-term trend Oct 30, 2021
No Benefit to Intensifying Diabetes Meds at Hospital Discharge Older adults discharged with intensified regimen had higher risk of severe hypoglycemia Oct 21, 2021
Birth Control Pills May Curb PCOS-Related Diabetes Risk Retrospective results lay groundwork for potential preventive treatment option Oct 14, 2021
FDA Nudges Restaurants, Food Manufacturers to Cut Sodium Voluntary guidance aims to reduce Americans' sodium intake by 12% Oct 13, 2021
